FdaApplication
NDA 215935
Identifiers
- fda_app_no: NDA215935
Properties
| Property | Value |
|---|---|
| applicant_name | CALLIDITAS THERAPEUTICS AB |
| application_type | NDA |
| approval_date | 2021-12-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TARPEYO | BUDESONIDE | 4MG | CAPSULE, DELAYED RELEASE;ORAL |
1 product